CSL Limited (ASX:CSL) Increases Dividend to $2.20 Per Share

CSL Limited (ASX:CSL) declared a final dividend on Thursday, September 5th, MarketIndexAU reports. Shareholders of record on Tuesday, October 1st will be given a dividend of 2.203 per share on Tuesday, October 1st. This represents a yield of 0.73%. The ex-dividend date of this dividend is Sunday, September 8th. This is a positive change from CSL’s previous final dividend of $1.99.

CSL Price Performance

The company has a quick ratio of 1.68, a current ratio of 2.17 and a debt-to-equity ratio of 62.80.

Insider Buying and Selling at CSL

In related news, insider Paul McKenzie bought 8,275 shares of the business’s stock in a transaction on Tuesday, September 3rd. The shares were bought at an average cost of A$306.03 ($208.18) per share, for a total transaction of A$2,532,398.25 ($1,722,719.90). In related news, insider Carolyn Hewson acquired 193 shares of the business’s stock in a transaction that occurred on Friday, August 16th. The shares were acquired at an average cost of A$305.34 ($207.71) per share, for a total transaction of A$58,930.04 ($40,088.46). Also, insider Paul McKenzie acquired 8,275 shares of the business’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were bought at an average price of A$306.03 ($208.18) per share, for a total transaction of A$2,532,398.25 ($1,722,719.90). 0.30% of the stock is currently owned by company insiders.

CSL Company Profile

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.